Columns - Pharmaceutical Executive

ADVERTISEMENT

Columns

Back Page: The "Help is Here" Express

June 1, 2006

Patient assistance programs have been around for a quarter of a century. But many patients have failed to reap the benefits because of confusion over eligibility and the mechanics of joining. But all that has become much easier with the Partnership for Prescription Assistance (PPA), a one-stop-shop for industry-sponsored assistance programs.

From the Editor: Forecast — and Fast

June 1, 2006

At the rate science is progressing, there may be more new knowledge in the next 25 years than in the past 100. That's great news, but not if you are planning to run your business as you run it today.

Toolkit: Safety in Numbers

June 1, 2006

Scott Gottlieb called RFID implementation "disappointing." Now, FDA is moderating its view of RFID as a cure-all for the industry.

Washington Report: Promises to Keep

June 1, 2006

Pharma follow-through? As of September 2005, drug manufacturers had promised to perform 1,200 post-marketing studies. Companies hadn't even started 65 percent of them, and only 200 were completed.

Global Report: People Problems

June 1, 2006

Staggering doses in clinical trials may prevent large numbers of people from experiencing serious side effects. But it presents practical and ethical dilemmas, such as determining who is going to be first in line for their dose.

Direct to Consumer: Hit 'Em Where It Helps

May 1, 2006

Although in-store promotional programs have the unique capability of reaching a large target audience, they currently make up less than one percent of total direct-to-consumer marketing expenditures.

Opinion: Brussels Sprouts

May 1, 2006

I've just returned from Europe, where I spoke with various think tanks, thought leaders, and pharmaceutical companies on the issue they call "information-to-patients" (ItP). That's what we on the other side of the pond refer to as direct-to-consumer communications. In Europe, they choose to abstain from using the "A" word—advertising. But rhetoric counts. "Information to patients" seems quite paternalistic when compared with the new-worldly "direct-to-consumer" moniker.

Marketing to Professionals: Ensuring Equality

May 1, 2006

There's a lot of controversy about BiDil. But there have always been medicines that worked better in some people. I think it's a positive if it gets physicians to understand what works for one patient versus another.

Alternative Media: Interactive=Integration

May 1, 2006

Media have become more fragmented than ever, and sales-force access to customers continues to decline. Pioneers must identify new solutions that improve on tradition.

ADVERTISEMENT

Click here